<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01380158</url>
  </required_header>
  <id_info>
    <org_study_id>2010-225</org_study_id>
    <nct_id>NCT01380158</nct_id>
  </id_info>
  <brief_title>Preventing Preterm Birth With a Pessary</brief_title>
  <acronym>PrePPy</acronym>
  <official_title>Preventing Preterm Birth With a Pessary</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington Hospital Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study, is to determine the effect of a Cup pessary, a device
      that is currently readily available in the USA and similar in design to the Arabin pessary,
      on the incidence of delivery prior to 37 weeks in women with a history of prior spontaneous
      birth (before 37 weeks) and incidentally found to have a cervix less than 25 mm in length
      prior to 23 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>delivery prior to 37 weeks of gestation</measure>
    <time_frame>within the first 30 days after delivery of the neonate</time_frame>
    <description>Gestational age at birth will be recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of birth less than seven days from randomization</measure>
    <time_frame>within the first 30 days after delivery of the neonate</time_frame>
    <description>Gestational age at birth will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Previable birth (&lt;24 weeks)</measure>
    <time_frame>within the first 30 days after delivery of the neonate</time_frame>
    <description>Gestational age at birth will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perinatal death</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 weeks</time_frame>
    <description>defined as either a stillbirth or postnatal death prior to hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low birth weight</measure>
    <time_frame>within the first 30 days after delivery of the neonate</time_frame>
    <description>Birthweight at delivery will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse neonatal outcomes</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 weeks</time_frame>
    <description>intraventricular hemorrhage, respiratory distress syndrome of the newborn, retinopathy of prematurity, or necrotizing enterocolitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for neonatal special care</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 weeks</time_frame>
    <description>ventilation, phototherapy, treatment for sepsis, blood transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications due to pessary</measure>
    <time_frame>Every 4 weeks while pregnant with pessary in situ</time_frame>
    <description>Incidence of bacterial vaginosis, urinary tract infections, vaginal erosions will be recorded at monthly visits.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">238</enrollment>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Pessary use during pregnancy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Cup pessary</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expectant management</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Expectant Management + weekly intramuscular progesterone injections</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cup pessary (Bioteque America, Inc)</intervention_name>
    <description>Placement of cup pessary in the vagina after randomization</description>
    <arm_group_label>Pessary use during pregnancy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancies in patients with a history of spontaneous preterm birth
             (previous delivery between 17 0/7 weeks and 36 6/7 weeks).

          -  Women ages 18 to 45 years of age

        Exclusion Criteria:

          -  Major fetal abnormalities (defined as those that are lethal or require prenatal or
             postnatal surgery), fetal death, or fetal growth restriction diagnosed before
             randomization.

          -  Presence of prophylactic cervical cerclage

          -  Significant maternal-fetal complications (treated chronic hypertension, insulin
             dependant diabetes mellitus, red cell isoimmunization)

          -  Painful regular uterine contractions, or ruptured membranes

          -  Visual cervical dilation of 2cm or greater and visible membranes.

          -  Patients with a pregnancy dated by an ultrasound after 20 weeks gestation.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rita W Driggers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington Hospital Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jasbir Singh, MD</last_name>
    <phone>202-877-3067</phone>
    <email>jasbir.singh@medstar.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rita W. Driggers, MD</last_name>
    <phone>202-877-7127</phone>
    <email>rita.w.driggers@medstar.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Georgetown University Hospital</name>
      <address>
        <city>Wasghington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helain Landy, MD</last_name>
      <phone>202-444-8757</phone>
      <email>helain.j.landy@m3dstar.net</email>
    </contact>
    <investigator>
      <last_name>Helain J Landy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Wasghinton</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasbir Singh, MD</last_name>
      <phone>202-877-3067</phone>
      <email>jasbir.singh@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Jasbir Singh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rita W Driggers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Franklin Square Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Smith, MD</last_name>
      <phone>443-777-8045</phone>
      <email>samuel.smith@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Samuel Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996 Feb 29;334(9):567-72.</citation>
    <PMID>8569824</PMID>
  </reference>
  <reference>
    <citation>Owen J, Hankins G, Iams JD, Berghella V, Sheffield JS, Perez-Delboy A, Egerman RS, Wing DA, Tomlinson M, Silver R, Ramin SM, Guzman ER, Gordon M, How HY, Knudtson EJ, Szychowski JM, Cliver S, Hauth JC. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol. 2009 Oct;201(4):375.e1-8. doi: 10.1016/j.ajog.2009.08.015.</citation>
    <PMID>19788970</PMID>
  </reference>
  <reference>
    <citation>Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ, Caritis SN, Iams JD, Wapner RJ, Conway D, O'Sullivan MJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003 Jun 12;348(24):2379-85. Erratum in: N Engl J Med. 2003 Sep 25;349(13):1299.</citation>
    <PMID>12802023</PMID>
  </reference>
  <reference>
    <citation>Vitsky M. Pessary treatment of the incompetent cervical os. Obstet Gynecol. 1968 May;31(5):732-3.</citation>
    <PMID>5646408</PMID>
  </reference>
  <reference>
    <citation>Oster S, Javert CT. Treatment of the incompetent cervix with the Hodge pessary. Obstet Gynecol. 1966 Aug;28(2):206-8.</citation>
    <PMID>5944837</PMID>
  </reference>
  <reference>
    <citation>Arabin B, Halbesma JR, Vork F, Hübener M, van Eyck J. Is treatment with vaginal pessaries an option in patients with a sonographically detected short cervix? J Perinat Med. 2003;31(2):122-33.</citation>
    <PMID>12747228</PMID>
  </reference>
  <reference>
    <citation>Antczak-Judycka A, Sawicki W, Spiewankiewicz B, Cendrowski K, Stelmachów J. [Comparison of cerclage and cerclage pessary in the treatment of pregnant women with incompetent cervix and threatened preterm delivery]. Ginekol Pol. 2003 Oct;74(10):1029-36. Polish.</citation>
    <PMID>14669390</PMID>
  </reference>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2011</study_first_submitted>
  <study_first_submitted_qc>June 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2011</study_first_posted>
  <last_update_submitted>July 7, 2011</last_update_submitted>
  <last_update_submitted_qc>July 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2011</last_update_posted>
  <responsible_party>
    <name_title>Jasbir Singh, MD</name_title>
    <organization>Washington Hospital Center</organization>
  </responsible_party>
  <keyword>pessary</keyword>
  <keyword>preterm birth</keyword>
  <keyword>short cervix</keyword>
  <keyword>cervical incompetence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

